LegoChem Biosciences Inc (141080) — Cash Flow-to-Debt Ratio
LegoChem Biosciences Inc (141080) has a Cash Flow-to-Debt Ratio of -0.31x as of March 2026, meaning its operating cash flow of ₩-46.62 Billion could theoretically repay 0% of its total liabilities (₩152.41 Billion) in one year. Explore long-term investment intensity of LegoChem Biosciences Inc to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
LegoChem Biosciences Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for LegoChem Biosciences Inc across 12 annual periods. Also explore total assets of LegoChem Biosciences Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for LegoChem Biosciences Inc (2014–2025)
Year-by-year debt coverage analysis for LegoChem Biosciences Inc. For market capitalisation and broader financial context, see how much is LegoChem Biosciences Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.77x | ₩-124.53 Billion | ₩160.69 Billion | ▼ -220.9% |
| 2024 | 0.64x | ₩78.48 Billion | ₩122.38 Billion | ▲ +142.5% |
| 2023 | -1.51x | ₩-62.24 Billion | ₩41.28 Billion | ▼ -595.8% |
| 2022 | -0.22x | ₩-7.14 Billion | ₩32.93 Billion | ▲ +82.2% |
| 2021 | -1.22x | ₩-42.05 Billion | ₩34.46 Billion | ▼ -94.9% |
| 2020 | -0.63x | ₩-14.89 Billion | ₩23.79 Billion | ▼ -172.0% |
| 2019 | 0.87x | ₩24.11 Billion | ₩27.73 Billion | ▲ +236.5% |
| 2018 | -0.64x | ₩-12.76 Billion | ₩20.02 Billion | ▼ -164.0% |
| 2017 | -0.24x | ₩-8.21 Billion | ₩34.03 Billion | ▲ +45.4% |
| 2016 | -0.44x | ₩-13.04 Billion | ₩29.49 Billion | ▼ -30.7% |
| 2015 | -0.34x | ₩-8.54 Billion | ₩25.26 Billion | ▲ +41.2% |
| 2014 | -0.57x | ₩-7.88 Billion | ₩13.71 Billion | — |